Home » Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
Bausch + Lomb announced today that it has completed its acquisition of ISTA Pharmaceuticals. The addition of ISTA bolsters Bausch + Lomb’s product portfolio and pipeline, increasing the company’s therapeutic offerings for physicians and their patients and creating opportunity for future growth.
MarketWatch
MarketWatch
Upcoming Events
-
07May
-
14May
-
30May